December 9, 2025

National HealthCare Corporation (NHC): Investor Outlook on a Healthcare Mainstay with a Solid Dividend Yield

National HealthCare Corporation (NHC) stands as a stalwart in the healthcare sector, offering an array of medical care services that cater to a diverse range of needs, from skilled nursing..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Strong Buy Ratings and 16% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is drawing considerable attention in the healthcare sector, particularly among investors seeking opportunities in the drug manufacturing space. Specializing in both specialty and generic pharmaceuticals,..

Aurinia Pharmaceuticals Inc (AUPH) Stock Report: Navigating the 6.29% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a prominent player in the biotechnology sector, is garnering attention from investors, particularly with an eye-catching 6.29% potential upside based on the average target price..

Veracyte, Inc. (VCYT) Investor Outlook: Unpacking a 7% Upside Potential in Healthcare Diagnostics

Veracyte, Inc. (NASDAQ: VCYT) stands as a notable player in the healthcare diagnostics and research industry, offering a suite of genomic tests designed to improve cancer diagnosis. With a market..

Agios Pharmaceuticals (AGIO) Stock Analysis: High Growth Potential Amidst Revenue Surge and Positive Ratings

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotechnology sector with its focus on pioneering treatments for rare genetic diseases through advancements in cellular metabolism. With a market capitalization..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 53.57% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector, presents a compelling opportunity for investors, with a potential upside of 53.57% based on its average target price. Headquartered..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook Reveals 39.81% Potential Upside

U.S. Physical Therapy, Inc. (USPH), a prominent player in the healthcare sector, offers a promising investment opportunity with a compelling potential upside of 39.81%. With a market capitalization of $1.15..

MiMedx Group, Inc (MDXG) Stock Analysis: A Potential 82% Upside in the Biotech Sector

MiMedx Group, Inc (NASDAQ: MDXG) is making waves in the biotechnology sector with a compelling growth narrative and an impressive potential upside of 82.63%. This Marietta, Georgia-based company, specializing in..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 32.83% Potential Upside for Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands as a compelling player within the biotechnology sector, particularly for investors interested in companies that focus on rare and orphan diseases. With a market..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Why a 23.94% Potential Upside Has Investors Buzzing

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector focusing on neurological and psychiatric disorders, has been capturing the attention of investors with its promising clinical pipeline..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a 186.67% Potential Upside in the Biotech Sector

ARS Pharmaceuticals, Inc. (SPRY), a dynamic player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 186.67%. This San Diego-based biopharmaceutical company is at the..

Harmony Biosciences Holdings (HRMY): Investor Outlook on a Promising 18.66% Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has emerged as a compelling player in the biotechnology sector, specifically within the healthcare industry. With a market capitalization of $2.24 billion, this U.S.-based..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a 8.60% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a pivotal player in the medical devices industry, stands as a noteworthy contender in the healthcare sector with a market capitalization of $1.41 billion...

PACS Group, Inc. (PACS) Stock Analysis: A Promising 13.82% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a notable player in the healthcare sector, has been making waves in the medical care facilities industry with its impressive financial growth and strategic operations. Headquartered..

CONMED Corporation (CNMD) Investor Outlook: Evaluating a Potential 23.74% Upside Amidst Market Challenges

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor interest with its compelling growth potential. The company’s current market..

Select Medical Holdings Corp (SEM) Stock Analysis: A 23% Potential Upside with Strong Analyst Support

Select Medical Holdings Corporation (NYSE: SEM) is capturing the attention of healthcare investors with its robust market presence and promising growth potential. Operating in the healthcare sector, SEM is a..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring a Potential 32.82% Upside for Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has been making waves in the biotechnology sector with its innovative immune medicine platform aimed at diagnosing and treating various diseases. Based in Seattle, Washington,..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A 15.76% Upside Potential in the Healthcare Sector

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, is capturing investor attention with its robust growth prospects and diverse service offerings. As a key provider of..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals a Promising 28.29% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is capturing the attention of investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $2.7..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 53.87% Upside Potential

Surgery Partners, Inc. (NASDAQ: SGRY) operates within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of approximately $2.16 billion, the company provides..

Search

Funds

December 9, 2025

Search

Funds

December 9, 2025

FTSE 100

Funds